Skip to main navigation Skip to search Skip to main content

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase

  • Yok Lam Kwong
  • , Thomas S.Y. Chan
  • , Daryl Tan
  • , Seok Jin Kim
  • , Li Mei Poon
  • , Benjamin Mow
  • , Pek Lan Khong
  • , Florence Loong
  • , Rex Au-Yeung
  • , Jabed Iqbal
  • , Colin Phipps
  • , Eric Tse
  • Queen Mary Hospital Hong Kong
  • Raffles Hospital
  • Singapore General Hospital
  • Sungkyunkwan University
  • National University Cancer Institute
  • Mount Elizabeth Medical Centre

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science